BullFrog AI is a technology-enabled drug discovery company using AI to aid in advancing the next generation of lifesaving medicine.
Brazilian Center for Research – CNPEM
CNPEM is a sophisticated and ebullient environment for research and development that is the only one of its kind in Brazil and found in only a few scientific centers in the world. The Center private, non-profit organization overseen by the Ministry of Science, Technology, and Innovation (MCTI). The Center is home to Sirius, the most complex project in Brazilian science and one of the world’s most advanced synchrotron light sources. CNPEM comprises highly specialized multi-thematic teams, globally competitive lab infrastructure that is open to the scientific community, strategic lines of research, innovative projects in partnerships with the productive sector, and training programs for researchers and students. CNPEM is an environment driven by research into solutions that impact the areas of health, energy and renewable materials, agro environmental and engineering. | The Brazilian Center for Research in Energy and Materials (CNPEM) is home to a state-of-the-art, multi-user and multidisciplinary scientific environment. A social organization overseen by the Ministry of Science, Technology and Innovation, CNPEM powers Brazil’s science with cutting-edge labs like Sirius, tackling global challenges in health, renewable materials, energy & sustainability.
Brainlab
Experience the future of surgical precision with Brainlab’s integrated ecosystem for orthopedic and spinal care. We showcase how connected data, advanced planning, and robotics empower surgeons to make confident, data-driven decisions. TraumaCad streamlines orthopedic planning, while Spine Mixed Reality Navigation and our Robotic Suite create a seamless, unified workflow. Quip Endoscopy enhances visualization, and Snke Dataspace connects patient data to unlock actionable insights. | Brainlab develops, manufactures and markets software-driven medical technology for precise, minimal invasive patient treatments. Core products center on the areas of information-guided surgery, radiosurgery and digital operating room (OR) integration. Brainlab technology enables hospitals to transform their operating rooms into the industry 4.0 of surgery with intelligent data exchange and digitally integrated technologies.
Brainlab / Mint Medical
At Brainlab, we digitize medical workflows, from diagnosis to therapy, to offer clinicians and patients better treatment possibilities. Our innovative digital ecosystem forms the basis for modern healthcare technology in 6700 hospitals in 127 countries. At the forefront of health technology for over 35 years, Munich-based Brainlab employs around 2400 people with expertise across the entire healthcare value chain in 25 locations worldwide.
Bracco
Bracco Imaging is a global leader in diagnostic imaging, dedicated to improving people’s lives by shaping the future of prevention and precision medicine. With a strong passion for innovation, the company develops and provides a broad portfolio of pharmaceutical products for diagnostic imaging: contrast agents for X-ray, Computed Tomography (CT), and Magnetic Resonance Imaging (MRI), as well microbubbles for Contrast Enhanced Ultrasound (CEUS), and Molecular Imaging through radioactive tracers and novel PET imaging agents, alongside specialized medical devices and related services. The company is committed to advancing radiology by sharing knowledge to cultivate future thought leaders, linking today’s practice with tomorrow’s progress. Since 1927, Bracco Imaging has grown to more than 3,800 employees and now supports patients and radiology professionals in over 100 countries. Discover Bracco Imaging at www.bracco.com | Bracco Imaging is a global leader in diagnostic imaging, dedicated to improving people’s lives by shaping the future of prevention and precision medicine. With a strong passion for innovation, the company develops and provides a broad portfolio of pharmaceutical products for diagnostic imaging: contrast agents for X-ray, Computed Tomography (CT), and Magnetic Resonance Imaging (MRI), as well microbubbles for Contrast Enhanced Ultrasound (CEUS), and Molecular Imaging through radioactive tracers and novel PET imaging agents, alongside specialized medical devices and related services.
BostonGene
BostonGene is redefining cancer patient care and drug development through the integration of omnimodal data and AI. Built and validated through an extensive real-world clinical testing network, BostonGene’s foundation model for tumor and immune biology integrates genomic, transcriptomic, and immune data with clinical outcomes to generate biologically grounded, actionable insights. These insights enable biopharma partners design and de-risk trials, identify novel targets, and optimize therapeutic response prediction while improving patient care through clinically integrated innovation.
BloodScan Biotech Inc.
BloodScan Biotech Inc. is a biotechnology company dedicated to precision oncology. Founded through technology transfer from a research team at the University of Michigan, BloodScan focuses on advancing innovations in liquid biopsy with the goal of becoming a key global driver in early cancer detection and disease monitoring. Our flagship product, Labyrinth One, is the world’s only liquid biopsy system capable of achieving tissue-biopsy-comparable performance. The system enables stable, fully automated enrichment of circulating tumor cells (CTCs) and delivers ultra-sensitive capabilities for early cancer screening and monitoring. Three Core Advantages: 1. Reliable CTC Isolation and Monitoring in Advanced Cancer – Enables disease monitoring and treatment response assessment in late-stage patients. 2. Tissue-Biopsy-Comparable Performance – Provides accuracy and biological integrity comparable to conventional histopathology. 3. Ultra-Sensitive Early Cancer Screening – Enhances early cancer detection rates to support more precise and timely treatment decisions. Our vision is to establish CTCs as a central pillar of next-generation cancer diagnostics, empowering healthcare systems worldwide to deliver earlier, more precise, and more personalized cancer care. | BloodScan Biotech Inc. Pioneering Liquid Biopsy for Precision Oncology BloodScan Biotech Inc. is a biotechnology company at the forefront of next-generation liquid biopsy technologies, committed to transforming cancer diagnostics through precision medicine. Established in 2023 as a spin-off from the University of Michigan, BloodScan focuses on advancing circulating tumor cell (CTC) isolation to improve early cancer detection, real-time treatment monitoring, and personalized therapeutic decision-making. The heart of BloodScan’s innovation is the Labyrinth One – Automated CTC Enrichment System, a compact, benchtop platform designed for high-throughput, label-free isolation of viable CTCs directly from blood samples. Unlike traditional antibody-based capture technologies, Labyrinth One utilizes microfluidic separation to deliver exceptional purity, recovery, and reproducibility—all within a 15-minute workflow. This allows for seamless integration into both clinical and research laboratory settings, enabling routine use of CTCs for diagnostics and translational oncology research. BloodScan’s mission is to bridge the gap between academic innovation and clinical implementation. Through strategic partnerships with research institutes, oncology centers, and clinical laboratories, the company aims to accelerate the adoption of liquid biopsy technologies and expand access to non-invasive cancer diagnostics that can meaningfully improve patient outcomes.
Blatek, Inc.
Blatek is a Manufacturer Of Custom Medical Ultrasonic Transducers And Piezoelectric Composites. We take great pride in our ability to meet customer needs and to deliver the ultrasound transducers they seek. Blatek transducers and piezo composites are designed and manufactured to meet specifications arrived at through consultation, experimentation, and collaboration with clients. Blatek advances the state of the art of the transducer and piezo composite industry with its commitment to innovation and its focus on continuous improvement.